Write in a clean editor, then format for HIV Clinical Trials in one click — DocuGuru applies the official Taylor & Francis template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
HIV Clinical Trials is a peer-reviewed journal published by Taylor & Francis, covering HIV/AIDS drug development and treatment, HIV-related health complications and treatments, HIV Research and Treatment.
| Publisher | Taylor & Francis |
|---|---|
| Reference style | Author–year (Chicago, T&F) Author–year — (Smith, 2023) in the text Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." HIV Clinical Trials 12 (3): 45–58.
Formats any DOI in HIV Clinical Trials style. No sign-up. |
| Publishes research in | HIV/AIDS drug development and treatment HIV-related health complications and treatments HIV Research and Treatment HIV/AIDS Research and Interventions Hepatitis C virus research |
| ISSN | 1528-4336 |
| h-index | 62 |
| i10-index | 470 |
| Total citations | 16,878 |
| Top institutions publishing here | Harvard University |
| Journal website | www.tandfonline.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
PURPOSE: To examine the performance of an instrument to assess adherence based on a visual analogue scale, compared to an instrument based on 3-day recall, using unannounced pill counts in the place of residence as the gold standard. METHOD: We prospectively assessed adherence to antiretroviral therapy in 84 marginally housed indigent HIV-infected patients who were…
PURPOSE: The purpose of our study was to assess short-term self-reported symptoms in patients who were started on two nucleoside reverse transcriptase inhibitors and one protease inhibitor (PI) in the multicenter APROCO cohort (N = 336) and to assess the influence of these symptoms on adherence. METHOD: Adherence and patient's reported symptoms were measured at…
BACKGROUND: As HIV-infected persons age, the relative contribution of HIV infection, combination antiretroviral therapy (cART), and the normal aging process to the frequent comorbidities is unknown. METHODS: We prospectively evaluated comorbidities, cardiovascular risk, cognitive function, and anthropomorphic and laboratory parameters of HIV-infected persons aged 50 years and over in two US urban clinics. Results were…
BACKGROUND: Study 903 is a phase 3 trial with a completed 144-week, double-blind phase comparing tenofovir DF (TDF) to stavudine (d4T) in combination with lamivudine (3TC) and efavirenz (EFV) and an ongoing additional 336-week open-label extension phase. METHOD: Patients in Brazil, Argentina, and the Dominican Republic who completed the 144-week double-blind phase on TDF were…
BACKGROUND: The effect of adherence on the risk of virologic failure and mutations selection was verified in a prospective study. METHOD: At baseline, all patients had a viral load (VL) <50 copies/mL and completed a self-reported questionnaire. Patients were followed for the subsequent 4 months to document virologic rebound (VL > 50 copies/mL). RESULTS: 1,133…
Enterprise Information Systems
International Journal of Computer Mathematics
International Journal of Remote Sensing
Journal of Intelligent Transportation Systems
Journal of the American Statistical Association
Nuclear Science and Engineering
Quality Engineering
Statistics in Biopharmaceutical Research
